Sundowning: Difference between revisions

No edit summary
No edit summary
 
(37 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<div class="editorbox">
<div class="editorbox">
'''Original Editor '''- Your name will be added here if you created the original content for this page.
'''Original Editor '''- [[User:Akano Oluwadara TomisinAkano Oluwadara Tomisin|Akano Oluwadara TomisinAkano Oluwadara Tomisin]]


'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}  &nbsp;   
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}  &nbsp;   
</div>  
</div>  
== Introduction ==
== Introduction ==
Sundowning or '''sundown syndrome''',<sup>[1]</sup> is a neurological phenomenon associated with increased confusion and restlessness in patients with delirium or some form of dementia. Most commonly associated with Alzheimer's disease, but also found in those with other forms of dementia, the term "sundowning" was coined due to the timing of the patient's confusion. It's also known as “late-day confusion". The term "sundowning" refers to a state of confusion occurring in the late afternoon and spanning into the night. It can cause a variety of behaviors, such as confusion, anxiety, aggression or ignoring directions. Also, it can lead to pacing or wandering. For patients with sundowning syndrome, a multitude of behavioral problems begin to occur in the evening or while the sun is setting.<sup>[2][3]</sup>[4
[[File:Sundowning 2.jpg|thumb]]
Sundowning  refers to a group of neuropsychiatric symptoms which develop late afternoon or during the evening and night time ( periods of diminishing daylight). It is commonly seen in individuals diagnosed with [[dementia]] or neurocognitive decline due to [[parkinson's]] or [[Alzheimer's Disease|alzheimer's]] disease  and in elderly institutionalized patients<ref name=":0">Khachiyants N, Trinkle D, Son S, Kim K. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246134/ Sundown syndrome in persons with dementia: an update.] Psychiatry investig, 2011; 8:275-87</ref>.


== Sub Heading 2 ==
Some of the common symptoms associated with sundowning include:<ref>Menegardo CS, Friggi FA, Scardini JB, Rossi TS, Vieira TD, Tieppo A, Morelato RL. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907707/ Sundown syndrome in patients with Alzheimer’s disease dementia.] Dementia & neuropsychologia. 2019 Dec 9;13:469-74.</ref>


== Sub Heading 3 ==
* Confusion,
* Anxiety,
* Aggression,
* Irritability
* Hallucination
* Pacing
* Changes in demeanour and affect
* Motor changes like restlessness, dyskinesia


== Resources  ==
Sundowning can negatively impact patient safety and wellbeing and  results in considerable caregiver [[Burnout and wellbeing|burnout]], it also poses increased demands on the health care providers especially the nursing staff.<ref name=":1" />
*bulleted list
== Etiology of Sundowning ==
*x
The etiology of Sundowning is complex and poorly understood.Changes in the normal circadian rhythm is one of the most common cause of sundowning  however other factors like medications, environmental changes, comorbidities all play a significant role in development of disruptive behaviours seen in sundowning  Some of the common factors are summarized in Table 1<ref name=":1" />.
or


#numbered list
[[File:Fmed-03-00073-t001.jpg|alt=|556x556px]]
#x
== Treatment of Sundowning  ==
The treatment for sundowning requires a team based approach. Coordination between the health care providers, patient  and the family members is quintessential. The treatment can be broadly divided between Pharmacologic and Nonpharmacologic approaches.
* Pharmacological Treatments:  The three groups of drugs that have shown some promise for the management of sundowning are: Melatonin supplementation, cholinesterase inhibitors  and antipsychotics<ref name=":1">[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907707/ Canevelli] M, Valletta M, Trebbastoni A, Sarli G, D’Antonio F, Tariciotti L, de Lena C, Bruno G. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907707/ Sundowning in dementia: clinical relevance, pathophysiological determinants, and therapeutic approaches.] Frontiers in medicine. 2016 Dec 27;3:73.</ref>.  However, more research is required.
* Non Pharmacological Treatments: This should be the first line of treatment for the management of sundowning. These include [[Environmental Physiotherapy- Introduction|environmental]] modifications, [[Physical Activity|physical activity,]] alternate therapy like [[Music therapy and children with cerebral palsy|music]], [[acupuncture]], tai-chi , light therapy, consistent routines, caregiver education etc.


== References  ==
== References  ==


<references />
<references />
[[Category:Older People/Geriatrics]]
[[Category:Older People/Geriatrics - Conditions]]

Latest revision as of 12:48, 30 December 2021

Introduction[edit | edit source]

Sundowning 2.jpg

Sundowning refers to a group of neuropsychiatric symptoms which develop late afternoon or during the evening and night time ( periods of diminishing daylight). It is commonly seen in individuals diagnosed with dementia or neurocognitive decline due to parkinson's or alzheimer's disease and in elderly institutionalized patients[1].

Some of the common symptoms associated with sundowning include:[2]

  • Confusion,
  • Anxiety,
  • Aggression,
  • Irritability
  • Hallucination
  • Pacing
  • Changes in demeanour and affect
  • Motor changes like restlessness, dyskinesia

Sundowning can negatively impact patient safety and wellbeing and results in considerable caregiver burnout, it also poses increased demands on the health care providers especially the nursing staff.[3]

Etiology of Sundowning[edit | edit source]

The etiology of Sundowning is complex and poorly understood.Changes in the normal circadian rhythm is one of the most common cause of sundowning however other factors like medications, environmental changes, comorbidities all play a significant role in development of disruptive behaviours seen in sundowning Some of the common factors are summarized in Table 1[3].

Treatment of Sundowning[edit | edit source]

The treatment for sundowning requires a team based approach. Coordination between the health care providers, patient and the family members is quintessential. The treatment can be broadly divided between Pharmacologic and Nonpharmacologic approaches.

  • Pharmacological Treatments: The three groups of drugs that have shown some promise for the management of sundowning are: Melatonin supplementation, cholinesterase inhibitors and antipsychotics[3]. However, more research is required.
  • Non Pharmacological Treatments: This should be the first line of treatment for the management of sundowning. These include environmental modifications, physical activity, alternate therapy like music, acupuncture, tai-chi , light therapy, consistent routines, caregiver education etc.

References[edit | edit source]

  1. Khachiyants N, Trinkle D, Son S, Kim K. Sundown syndrome in persons with dementia: an update. Psychiatry investig, 2011; 8:275-87
  2. Menegardo CS, Friggi FA, Scardini JB, Rossi TS, Vieira TD, Tieppo A, Morelato RL. Sundown syndrome in patients with Alzheimer’s disease dementia. Dementia & neuropsychologia. 2019 Dec 9;13:469-74.
  3. 3.0 3.1 3.2 Canevelli M, Valletta M, Trebbastoni A, Sarli G, D’Antonio F, Tariciotti L, de Lena C, Bruno G. Sundowning in dementia: clinical relevance, pathophysiological determinants, and therapeutic approaches. Frontiers in medicine. 2016 Dec 27;3:73.